Sun Pharma, India's largest drug maker, said its step-down US subsidiary Taro Pharmaceuticals has acquired companies of Galderma in the US, Japan and Canada. Galderma specialises in skin related disorders Taro Pharmaceuticals USA, one of the wholly owned subsidiaries of our Taro Pharmaceutical Industries, has agreed to acquire all of the outstanding capital stock of Galderma Holdings Inc (incorporated in Delaware); Proactiv YK (incorporated in Japan); The Proactiv Company Corporation (incorporated in Canada); and other assets of The Proactiv Company Sari, used in the business of developing, manufacturing, marketing, selling and distributing products sold under the Proactiv, Restorative Elements and In Defense of Skin brands," Sun Pharmaceutical said in an exchange filing. The brands will help Taro to boost its dermatology portfolio in the US. Shares of Sun Pharma rose 1.84% to 871.25 on BSE at 2.45 pm on Wednesday, the benchmark Sensex gained 2.47% to 54,700.42 points
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!